These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 11363901)

  • 61. Immunologic approaches to the therapy of HIV-1 infection.
    Sneller MC; Lane HC
    Ann N Y Acad Sci; 1993 Jun; 685():687-96. PubMed ID: 8363275
    [No Abstract]   [Full Text] [Related]  

  • 62. Intrigue grows around Redfield report.
    Science; 1993 Jul; 261(5119):283. PubMed ID: 8332893
    [No Abstract]   [Full Text] [Related]  

  • 63. Surrogate markers in AIDS research. Is there truth in numbers?
    Levy JA
    JAMA; 1996 Jul; 276(2):161-2. PubMed ID: 8656510
    [No Abstract]   [Full Text] [Related]  

  • 64. AIDS vaccines. Army investigates researcher's report of clinical trial data.
    Cohen J
    Science; 1992 Nov; 258(5084):883-4. PubMed ID: 1439797
    [No Abstract]   [Full Text] [Related]  

  • 65. Immune-based therapies at the retrovirus conference.
    Raymond D
    Posit Aware; 2003; 14(3):16-7. PubMed ID: 12866485
    [No Abstract]   [Full Text] [Related]  

  • 66. HIV vaccine--immune response. AG 1661, IR-8101, IR8101, REMUNE, RG 83894.
    Drugs R D; 2002; 3(6):411-20. PubMed ID: 12516948
    [No Abstract]   [Full Text] [Related]  

  • 67. Viral load: to treat or not to treat?
    Steele FR
    Nat Med; 1995 Oct; 1(10):980. PubMed ID: 7489377
    [No Abstract]   [Full Text] [Related]  

  • 68. Effectiveness of remune.
    Glidden D; Kim S; Lagakos S
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):468-9. PubMed ID: 11324587
    [No Abstract]   [Full Text] [Related]  

  • 69. First phase-3 HIV vaccine trial--hype or hope?
    Morris K
    Lancet Infect Dis; 2003 Apr; 3(4):186. PubMed ID: 12679257
    [No Abstract]   [Full Text] [Related]  

  • 70. Sometimes help may not be enough.
    Lederman MM; Douek DC
    AIDS; 2003 May; 17(8):1249-51. PubMed ID: 12819528
    [No Abstract]   [Full Text] [Related]  

  • 71. Therapeutic HIV vaccine nears registration.
    Burton A
    Lancet Infect Dis; 2002 Oct; 2(10):584. PubMed ID: 12383596
    [No Abstract]   [Full Text] [Related]  

  • 72. Immune-based therapy in HIV.
    Gandhi RT
    Hopkins HIV Rep; 2003 Mar; 15(2):4. PubMed ID: 12739500
    [No Abstract]   [Full Text] [Related]  

  • 73. [Specific immunotherapy for HIV infection: objectives and limits].
    Levy Y
    Therapie; 2005; 60(3):267-9. PubMed ID: 16128269
    [No Abstract]   [Full Text] [Related]  

  • 74. Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control.
    Bartha I; McLaren PJ; Brumme C; Harrigan R; Telenti A; Fellay J
    PLoS Comput Biol; 2017 Feb; 13(2):e1005339. PubMed ID: 28182649
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fighting HIV with HIV.
    Secasan IS; Pop DI
    Med Hypotheses; 1998 Jan; 50(1):39-42. PubMed ID: 9488180
    [No Abstract]   [Full Text] [Related]  

  • 76. Clinical trials. Company, researchers battle over data access.
    Morton CC
    Science; 2000 Nov; 290(5494):1063. PubMed ID: 11184994
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum HIV-1 RNA and routine patient monitoring.
    Phillips AN; Sabin CA; Mocroft A
    Lancet; 1995 Jun; 345(8962):1441. PubMed ID: 7760634
    [No Abstract]   [Full Text] [Related]  

  • 78. A change of tune.
    Kresge KJ; McEnery R
    IAVI Rep; 2010; 14(5):4-12. PubMed ID: 21158224
    [No Abstract]   [Full Text] [Related]  

  • 79. Progress towards obtaining an HIV cure: slow but sure.
    Henrich TJ; Lelièvre JD
    Curr Opin HIV AIDS; 2018 Sep; 13(5):381-382. PubMed ID: 29965799
    [No Abstract]   [Full Text] [Related]  

  • 80. Encouraging HIV positive people to participate in clinical trials.
    Williams JH
    BMJ; 1999 Sep; 319(7212):787-8. PubMed ID: 10488031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.